from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Record returned to U.S.C.A. for District of Columbia Circuit.
Record returned to U.S.C.A. for Fedral Circuit.
JUDGMENT ISSUED.
Judgment REVERSED and case REMANDED. Kagan, J., delivered the opinion for a unanimous Court. Sotomayor, J., filed a concurring opinion.
Record from U.S.D.C. for Eastern District of Michigan is electronic.
Argued. For petitioners: James F. Hurst, Chicago, Ill.; and Benjamin J. Horwich, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondents: Mark A. Perry, Washington, D. C.
Reply of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED. (orders list)
Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. (Distributed)
Brief amicus curiae of Washington Legal Foundation filed. (Distributed)
Brief amici curiae of Allergan, Inc., et al. filed. (Distributed)
Brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
Record received from U.S.C.A. for Federal Circuit. (1 box)
CIRCULATED
SET FOR ARGUMENT ON Monday, December 5, 2011.
Brief amici curiae of AARP and U.S. PIRG filed.
Brief amicus curiae of United States filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Brief amicus curiae of Rep. Henry A. Waxman filed.
Brief amicus curiae of Mylan Pharmaceuticals, Inc. filed.
Brief of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed.
Joint appendix filed (two volumes). (Statement of costs filed)
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents.
The time to file the joint appendix and petitioners' brief on the merits is extended to and including August 29, 2011.
The time to file respondents' brief on the merits is extended to and including October 17, 2011.
Petition GRANTED. (orders list)
Supplemental brief of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed. (Distributed)
Supplemental brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. filed.
Brief amicus curiae of United States filed.
The Acting Solicitor General is invited to file a brief in this case expressing the views of the United States.
Reply of petitioners Caraco Pharmaceutical Laboratories, Ltd., et al. filed.
Brief of respondents Novo Nordisk A/S, and Novo Nordisk Inc. in opposition filed.
Brief amicus curiae of Apotex, Inc. filed.
Brief amicus curiae of Teva Pharmaceuticals USA, Inc. filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Brief amici curiae of Consumer Federation of America and U.S. PIRG filed.
Brief amicus curiae of Mylan Pharmaceuticals, Inc. filed.
Order extending time to file response to petition to and including February 25, 2011.
Petition for a writ of certiorari filed. (Response due January 27, 2011)
Application (10A380) granted by The Chief Justice extending the time to file until December 23, 2010.
Application (10A380) to extend the time to file a petition for a writ of certiorari from October 27, 2010 to December 26, 2010, submitted to The Chief Justice.
Caraco Pharmaceutical Laboratories, Ltd., Petitioner, represented by Charles B. Klein
Caraco Pharmaceutical Laboratories, Ltd., et al., Petitioner, represented by Charles B. Klein
Caraco Pharmaceutical Laboratories, Ltd., et al., Petitioner, represented by Steffen N. Johnson
Novo Nordisk A/S, and Novo Nordisk Inc., Respondent, represented by Mark A. Perry
Novo Nordisk A/S, et al., Respondent, represented by Mark A. Perry
Allergan, Inc., et al., Amicus Curiae, represented by Jonathan E. Singer
Allergan, Inc., et al., Amicus Curiae, represented by Jonathan Singer
Apotex, Inc., Amicus Curiae, represented by Shashank S. Upadhye
Caraco Pharmaceutical Laboratories, Ltd., et al. v. Novo Nordisk A/S, et al., Amicus Curiae, represented by Benjamin Horwich
Consumer Federation of America and U.S, PIRG, Amicus Curiae, represented by David A. Balto
Generic Pharmaceutical Association, Amicus Curiae, represented by Roy T. Englert Jr.
Mylan Pharmaceuticals, Inc., Amicus Curiae, represented by Dan L. Bagatell
Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Robert A. Long Jr.
Rep. Henry A. Waxman, Amicus Curiae, represented by Carlos T. Angulo
Teva Pharmaceuticals USA, Inc., Amicus Curiae, represented by Michael D. Shumsky
United States, Amicus Curiae, represented by Donald B. Verrilli Jr.
United States, Amicus Curiae, represented by Neal Kumar Katyal
Washington Legal Foundation, Amicus Curiae, represented by Richard A. Samp